Citius Pharmaceuticals Inc (CTXR)

1.94 -0.09  -4.43% NASDAQ Oct 22, 16:00 1.95 +0.01  +0.52% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CTXR News


View All Events


Date Type Description
12/16/2021 Earnings Results Q4 2021 Earnings Results
08/12/2021 Earnings Results Q3 2021 Earnings Results
05/13/2021 Earnings Results Q2 2021 Earnings Results
02/11/2021 Earnings Results Q1 2021 Earnings Results
02/09/2021 08:00 EST AGM 2020 Annual General Meeting
12/16/2020 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.
  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Dec. 16, 2021
  • Last Earnings Release: Aug. 12, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
LOPX Direxion Low Priced Stock ETF 1.95%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.